Engineered Antibody

As highlighted by recent approvals, engineered antibodies now represent over 30% of biopharmaceuticals in clinical trials. Different antibody-based reagents have gained prominence in the pharmaceutical market.

https://www.creativebiolabs.net/engineered-antibodies.htm